Merit Medical Systems | MMSI - Sales Revenues

Stock Price
78.01
Daily Change
-1.22 -1.54%
Monthly
-5.33%
Yearly
-20.80%
Q1 Forecast
79.66

Merit Medical Systems reported $393.9M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
3M USD 6.1B 200M Dec/2025
Abbott USD 11.46B 90M Dec/2025
AngioDynamics USD 72M 841K Feb/2025
Anika Therapeutics USD 26.17M 12.58M Mar/2025
AtriCure USD 140.5M 6.2M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
J&J USD 24.6B 610M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Olympus JPY 261.05B 13.21B Dec/2025
Pfizer USD 17.58B 880M Dec/2025
STAAR Surgical USD 94.7M 50.4M Sep/2025
Stryker USD 7.2B 1.14B Dec/2025
Surmodics USD 29.92M 96.16M Dec/2024
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025